Genomic consequences of aberrant DNA repair stratify ovarian cancer histotypes

被引：0
|
作者：
Wang, Yikan
Bashashati, Ali
Anglesio, Michael S.
Cochrane, Dawn
Grewal, Diljot
Horlings, Hugo
Karnezis, Anthony
Mes-Masson, Anne-Marie
Okamoto, Aikou
Yanagida, Satoshi
Yanaihara, Nozomu
Saito, Misato
Gilks, Blake
McAlpine, Jessica
Aparicio, Samuel
Huntsman, David
Shah, Sohrab
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-LB-324
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-324
引用
收藏
页数：3
相关论文
共 50 条
  • [41] DNA repair status in a patient derived ovarian cancer xenobank
    Guffanti, Federica
    Fratelli, Maddalena
    Ganzinelli, Monica
    Ricci, Francesca
    Affatato, Roberta
    Cappelletti, Maria Rosa
    Generali, Daniele
    Bizzaro, Francesca
    Broggini, Massimo
    Giavazzi, Raffaella
    Damia, Giovanna
    CANCER RESEARCH, 2017, 77
  • [42] Targeting DNA repair and replication stress in the treatment of ovarian cancer
    Murai, Junko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (04) : 619 - 628
  • [43] DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC
    Flasarova, Dominika
    Urban, Katerina
    Strouhal, Ondrej
    Klos, Dusan
    Lemstrova, Radmila
    Dvorak, Pavel
    Soucek, Pavel
    Mohelnikova-Duchonova, Beatrice
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [44] DNA-repair pathway inhibitors for the treatment of ovarian cancer
    Martinek, Igor
    Haldar, Krishnayan
    Gaitskell, Kezia
    Bryant, Andrew
    Nicum, Shibani
    Kehoe, Sean
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [45] DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
    Stefanou, Dimitra T.
    Souliotis, Vassilis L.
    Zakopoulou, Roubini
    Liontos, Michalis
    Bamias, Aristotelis
    BIOMEDICINES, 2022, 10 (01)
  • [46] Targeting DNA repair and replication stress in the treatment of ovarian cancer
    Junko Murai
    International Journal of Clinical Oncology, 2017, 22 : 619 - 628
  • [47] Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?
    Bednarikova, Marketa
    Hausnerova, Jitka
    Ehrlichova, Lucie
    Matulova, Kvetoslava
    Gazarkova, Eliska
    Minar, Lubos
    Weinberger, Vit
    CANCERS, 2022, 14 (10)
  • [48] Exploring somatic DNA structural alteration and aberrant genomic interactions in cancer through GenomePaint
    Liu, Yu
    Zhou, Xin
    Wang, Jian
    Shao, Ying
    Easton, John
    Zimmerman, Mark W.
    Abraham, Brian J.
    Look, A. Thomas
    Zhang, Jinghui
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Use of genomic markers to risk stratify men with prostate cancer
    Davis, John W.
    TRENDS IN UROLOGY & MENS HEALTH, 2015, 6 (03) : 36 - 39
  • [50] Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer
    Webster, Andrew L. H.
    Sanders, Mathijs A.
    Patel, Krupa
    Dietrich, Ralf
    Noonan, Raymond J.
    Lach, Francis P.
    White, Ryan R.
    Goldfarb, Audrey
    Hadi, Kevin
    Edwards, Matthew M.
    Donovan, Frank X.
    Hoogenboezem, Remco M.
    Jung, Moonjung
    Sridhar, Sunandini
    Wiley, Tom F.
    Fedrigo, Olivier
    Tian, Huasong
    Rosiene, Joel
    Heineman, Thomas
    Kennedy, Jennifer A.
    Bean, Lorenzo
    Rosti, Rasim O.
    Tryon, Rebecca
    Gonzalez, Ashlyn-Maree
    Rosenberg, Allana
    Luo, Ji-Dung
    Carroll, Thomas S.
    Shroff, Sanjana
    Beaumont, Michael
    Velleuer, Eunike
    Rastatter, Jeff C.
    Wells, Susanne, I
    Surralles, Jordi
    Bagby, Grover
    MacMillan, Margaret L.
    Wagner, John E.
    Cancio, Maria
    Boulad, Farid
    Scognamiglio, Theresa
    Vaughan, Roger
    Beaumont, Kristin G.
    Koren, Amnon
    Imielinski, Marcin
    Chandrasekharappa, Settara C.
    Auerbach, Arleen D.
    Singh, Bhuvanesh
    Kutler, David, I
    Campbell, Peter J.
    Smogorzewska, Agata
    NATURE, 2022, 612 (7940) : 495 - +
12345